bioAffinity Technologies, Inc. SEC filings BIAFW

bioAffinity Technologies, Inc. has 399 filings in SEC EDGAR's recent list, going back to Jul 26, 2017. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.

bioAffinity Technologies, Inc. SEC filings
Form Description Filed Period
424B5 Prospectus supplement Nov 3, 2026 —
424B5 Prospectus supplement Nov 2, 2026 —
8-K Current report
Other events
Oct 29, 2026 Oct 29, 2026
DEF 14A Proxy statement Oct 23, 2026 Oct 23, 2026
8-K Current report
Other events
Oct 15, 2026 Oct 15, 2026
8-K Current report
Other events
Oct 13, 2026 Oct 13, 2026
PRER14A Filing Oct 13, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 9, 2026 Oct 8, 2026
424B5 Prospectus supplement Oct 9, 2026 —
424B5 Prospectus supplement Oct 9, 2026 —
8-K Current report
Other events
Oct 8, 2026 Oct 8, 2026
8-K Current report
Other events
Oct 6, 2026 Oct 6, 2026
8-K Current report
Other events
Sep 30, 2026 Sep 30, 2026
PRE 14A Preliminary proxy statement Sep 29, 2026 Sep 29, 2026
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
8-K Current report
Other events
Sep 17, 2026 Sep 17, 2026
8-K Current report
Regulation FD disclosure
Sep 11, 2026 Sep 11, 2026
8-K Current report
Other events
Sep 9, 2026 Sep 8, 2026
424B3 Prospectus Sep 8, 2026 —
EFFECT Filing Sep 4, 2026 —
8-K Current report
Other events
Sep 3, 2026 Sep 3, 2026
S-3/A Filing Sep 3, 2026 —
8-K Current report
Other events
Sep 1, 2026 Sep 1, 2026
S-3 Shelf registration Aug 27, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Aug 20, 2026 Aug 20, 2026
8-K Current report
Other events
Aug 18, 2026 Aug 18, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 14, 2026 Aug 12, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 7, 2026 Aug 7, 2026
8-K Current report
Listing notice
Jul 31, 2026 Jul 30, 2026
8-K Current report
Other events
Jul 27, 2026 Jul 27, 2026
8-K Current report
Other events
Jul 22, 2026 Jul 22, 2026
8-K Current report
Other events
Jul 7, 2026 Jul 7, 2026
8-K Current report
Other events
Jun 30, 2026 Jun 30, 2026
8-K Current report
Material agreement, Other events
Jun 18, 2026 Jun 16, 2026
424B4 Prospectus Jun 18, 2026 —
EFFECT Filing Jun 16, 2026 —
S-1/A Amended registration statement Jun 16, 2026 —
8-K Current report
Other events
Jun 16, 2026 Jun 16, 2026
CORRESP Letter to the SEC Jun 12, 2026 —
S-1 Registration statement Jun 12, 2026 —
8-K Current report
Other events
Jun 2, 2026 Jun 2, 2026
8-K Current report
Other events
May 27, 2026 May 27, 2026
S-8 Employee stock plan registration May 20, 2026 —
424B3 Prospectus May 14, 2026 —
EFFECT Filing May 12, 2026 —
8-K Current report
Other events
May 12, 2026 May 12, 2026
CORRESP Letter to the SEC May 11, 2026 —
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 8, 2026 May 8, 2026
UPLOAD Letter from the SEC May 7, 2026 —
UPLOAD Letter from the SEC May 7, 2026 —
DRS Filing Apr 30, 2026 —
S-1 Registration statement Apr 30, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Apr 30, 2026 Apr 30, 2026
8-K Current report
Other events
Apr 14, 2026 Apr 14, 2026
8-K Current report
Other events
Apr 7, 2026 Apr 7, 2026
8-K Current report
Other events
Apr 1, 2026 Apr 1, 2026
8-K Current report
Regulation FD disclosure
Mar 26, 2026 Mar 26, 2026
8-K Current report
Other events
Mar 25, 2026 Mar 25, 2026
8-K Current report
Other events
Mar 17, 2026 Mar 17, 2026
ARS Annual report to shareholders Mar 16, 2026 Dec 31, 2025
DEF 14A Proxy statement Mar 16, 2026 Mar 16, 2026
10-K Annual report Mar 16, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 13, 2026 Mar 13, 2026
8-K Current report
Other events
Mar 10, 2026 Mar 10, 2026
8-K Current report
Officer or director change
Mar 6, 2026 Mar 5, 2026
PRE 14A Preliminary proxy statement Mar 5, 2026 Mar 5, 2026
8-K Current report
Other events
Mar 3, 2026 Mar 3, 2026
8-K Current report
Other events
Feb 25, 2026 Feb 25, 2026
8-K Current report
Other events
Feb 19, 2026 Feb 19, 2026
8-K Current report
Other events
Feb 17, 2026 Feb 17, 2026
8-K Current report
Regulation FD disclosure
Feb 10, 2026 Feb 10, 2026
8-K Current report
Other events
Feb 9, 2026 Feb 9, 2026
8-K Current report
Other events
Feb 4, 2026 Feb 4, 2026
8-K Current report
Other events
Jan 7, 2026 Jan 7, 2026
8-K Current report
Other events
Dec 22, 2025 Dec 22, 2025
8-K Current report
Other events
Dec 19, 2025 Dec 19, 2025
8-K Current report
Other events
Dec 3, 2025 Dec 3, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
DEFA14A Additional proxy material Nov 12, 2025 —
DEF 14A Proxy statement Nov 7, 2025 Nov 7, 2025
8-K Current report
Other events
Nov 5, 2025 Nov 5, 2025
8-K Current report
Other events
Oct 28, 2025 Oct 28, 2025
PRER14A Filing Oct 27, 2025 —
8-K Current report
Other events
Oct 20, 2025 Oct 20, 2025
8-K Current report
Other events
Oct 16, 2025 Oct 16, 2025
8-K Current report
Other events
Oct 15, 2025 Oct 14, 2025
8-K Current report
Material agreement, Other events
Oct 9, 2025 Oct 8, 2025
424B5 Prospectus supplement Oct 9, 2025 —
PRE 14A Preliminary proxy statement Oct 8, 2025 Oct 8, 2025
8-K Current report
Other events
Oct 7, 2025 Oct 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 1, 2025 —
8-K Current report
Material agreement, Other events
Sep 30, 2025 Sep 29, 2025
424B4 Prospectus Sep 30, 2025 —
EFFECT Filing Sep 29, 2025 —
CORRESP Letter to the SEC Sep 26, 2025 —
CORRESP Letter to the SEC Sep 26, 2025 —
3 Initial insider ownership Sep 25, 2025 Aug 12, 2025
3 Initial insider ownership Sep 25, 2025 Aug 12, 2025
S-1/A Amended registration statement Sep 25, 2025 —
CORRESP Letter to the SEC Sep 24, 2025 —
S-1 Registration statement Sep 24, 2025 —
424B3 Prospectus Sep 18, 2025 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Sep 17, 2025 Sep 17, 2025
EFFECT Filing Sep 16, 2025 —
CORRESP Letter to the SEC Sep 16, 2025 —
S-1/A Amended registration statement Sep 15, 2025 —
8-K Current report
Other events
Sep 9, 2025 Sep 9, 2025
8-K Current report
Regulation FD disclosure
Sep 5, 2025 Sep 5, 2025
8-K Current report
Other events
Sep 3, 2025 Sep 3, 2025
UPLOAD Letter from the SEC Sep 3, 2025 —
8-K Current report
Material agreement
Sep 2, 2025 Sep 2, 2025
S-1 Registration statement Aug 29, 2025 —
UPLOAD Letter from the SEC Aug 26, 2025 —
DRS Filing Aug 22, 2025 —
8-K Current report
Officer or director change, Other events
Aug 18, 2025 Aug 12, 2025
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Aug 14, 2025 Aug 13, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Listing notice, Other events
Aug 13, 2025 Aug 7, 2025
8-K Current report
Other events
Jul 31, 2025 Jul 29, 2025
8-K Current report
Shareholder vote results
Jul 25, 2025 Jul 25, 2025
8-K Current report
Other events
Jul 23, 2025 Jul 23, 2025
8-K Current report
Other events
Jul 22, 2025 Jul 22, 2025
8-K Current report
Other events
Jul 15, 2025 Jul 15, 2025
EFFECT Filing Jul 3, 2025 —
EFFECT Filing Jul 3, 2025 —
POS AM Filing Jun 27, 2025 —
POS AM Filing Jun 27, 2025 —
ARS Annual report to shareholders Jun 2, 2025 Dec 31, 2024
DEFA14A Additional proxy material Jun 2, 2025 —
DEF 14A Proxy statement Jun 2, 2025 Jun 2, 2025
8-K Current report
Listing notice
May 30, 2025 May 27, 2025
8-K Current report
Material agreement
May 27, 2025 May 22, 2025
424B5 Prospectus supplement May 27, 2025 —
PRER14A Filing May 23, 2025 —
8-K Current report
Other events
May 19, 2025 May 19, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
SCHEDULE 13G Ownership over 5% (passive) May 14, 2025 —
8-K Current report
Material agreement, Other events
May 8, 2025 May 5, 2025
424B4 Prospectus May 7, 2025 —
EFFECT Filing May 5, 2025 —
S-1/A Amended registration statement May 5, 2025 —
CORRESP Letter to the SEC May 2, 2025 —
CORRESP Letter to the SEC May 2, 2025 —
S-1 Registration statement May 2, 2025 —
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
424B3 Prospectus Apr 22, 2025 —
EFFECT Filing Apr 18, 2025 —
UPLOAD Letter from the SEC Apr 18, 2025 —
CORRESP Letter to the SEC Apr 16, 2025 —
UPLOAD Letter from the SEC Apr 16, 2025 —
DRSLTR Filing Apr 15, 2025 —
DRS Filing Apr 15, 2025 —
PRE 14A Preliminary proxy statement Apr 15, 2025 Apr 15, 2025
8-K Current report
Officer or director change
Apr 14, 2025 Apr 12, 2025
S-1 Registration statement Apr 11, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 7, 2025 Mar 6, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
Feb 27, 2025 Feb 25, 2025
424B5 Prospectus supplement Feb 25, 2025 —
424B5 Prospectus supplement Feb 25, 2025 —
8-K Current report
Listing notice
Feb 7, 2025 Feb 7, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
8-K Current report
Officer or director change
Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
8-K Current report
Shareholder vote results
Dec 23, 2024 Dec 20, 2024
8-K Current report
Regulation FD disclosure
Dec 20, 2024 Dec 19, 2024
424B3 Prospectus Dec 9, 2024 —
EFFECT Filing Dec 6, 2024 —
CORRESP Letter to the SEC Dec 4, 2024 —
UPLOAD Letter from the SEC Dec 4, 2024 —
S-1 Registration statement Nov 27, 2024 —
424B3 Prospectus Nov 22, 2024 —
424B3 Prospectus Nov 22, 2024 —
424B3 Prospectus Nov 22, 2024 —
DEF 14A Proxy statement Nov 22, 2024 Nov 22, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
PRE 14A Preliminary proxy statement Nov 12, 2024 Nov 12, 2024
4 Insider transaction Nov 5, 2024 Nov 5, 2024
D Filing Oct 29, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Oct 21, 2024 Oct 17, 2024
424B5 Prospectus supplement Oct 21, 2024 —
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 10, 2024 Oct 4, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 9, 2024 Oct 9, 2024
8-K Current report
Shareholder vote results
Oct 7, 2024 Oct 2, 2024
424B3 Prospectus Sep 23, 2024 —
3 Initial insider ownership Sep 20, 2024 Sep 16, 2024
EFFECT Filing Sep 19, 2024 —
CORRESP Letter to the SEC Sep 17, 2024 —
UPLOAD Letter from the SEC Sep 16, 2024 —
S-1 Registration statement Sep 11, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
BIAF (Nasdaq), BIAFW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Antonio, TX
SEC filer status
, Emerging growth company
SEC CIK
1712762
Former names
bioAffinity Technologies, Inc. (until Nov 3, 2026)

Other Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.